Global Cardiac Pacemaker Devices Market
The Global Cardiac Pacemaker Devices Market will grow at a CAGR of 3.3%
from 2017 to 2022 to reach USD 4,629.3 million by 2022, according to the latest
publication from Meticulous Research®. The global cardiac pacemaker
devices market is majorly driven by increasing incidence & prevalence of
chronic cardiovascular diseases and technological advancements in the area of
implantable cardiac pacemakers. In addition, emerging markets and increasing
awareness of healthcare further provides a great opportunity for various
stakeholders in this market. However, increase in reported cases of cardiac
pacemaker malfunctioning & related product recalls restricts the growth of
the market to some extent.
Key Market Segments to
Watch
The
global cardiac pacemaker devices market is mainly segmented by product, end-user,
and geography. On the basis of product, cardiac pacemaker devices market is
segmented into cardiac pacemakers, pacing leads, and pacing analyzers. Cardiac
pacemaker segment held the largest share of this market, primarily due to
rising adoption of cardiac pacing systems for the prevention & better
management of sudden cardiac arrest in high-risk patients with cardiovascular
disease and the higher price of pacemakers in comparison with pacing leads
& analyzers. In addition, increasing incidence of cardiovascular disorders
with rising geriatric population, obesity, sedentary lifestyle, unhealthy food;
and rising demand for innovative products with technological advancements will
further drive the growth of cardiac pacemakers market.
Browse
in-depth Report on: https://www.meticulousresearch.com/product/cardiac-pacemaker-devices-market-forecast-2022/
Cardiac pacemakers market
is further sub-segmented into the implantable pacemaker and external pacemaker.
Implantable pacemakers are largely used for the prevention of sudden cardiac
arrest (SCA) and related deaths in patients at high risk for SCA with
increasing incidence of hypertension and atrial fibrillation. In addition,
increasing trend of acceptance of modern therapies with growing awareness
towards healthcare will further support the growth of this market.
On the basis of end-user,
cardiac pacemaker devices market is segmented into hospitals, ambulatory
surgery centers, and others. Hospitals hold the largest share of this market,
mainly due to a large pool of patients visiting hospitals and clinics across
the globe for diagnosis & treatment of healthcare concerns including
cardiovascular diseases.
Regional Market Growth
Trends
By geography, the market
is segmented into five major geographies namely: North America, Europe,
Asia-Pacific, Latin America, and Middle East & Africa. North America holds
the major share of the global cardiac pacemaker devices market in 2016,
followed by Europe, and Asia-Pacific. The large share of this region is
primarily attributed to the increasing incidence of cardiovascular diseases with
rising greying population and increasing burden of hypertension;
well-established healthcare system & distribution channel; higher spending
on healthcare; and presence of leading players in this market. However,
Asia-Pacific market will outpace the other cardiac pacemaker markets during the
forecast period, owing to rising incidence & prevalence of cardiovascular
diseases with increasing greying population, increasing the burden of
hypertension, growing obesity, and changing lifestyles. In addition, factors
such as improving healthcare infrastructure, rising awareness about pacemaker
therapy with various government initiatives, increasing healthcare spending,
rising affordability of middle-class population, and increasing urbanization
are further expected to boost the growth of cardiac pacemaker market in this
region.
Top Companies in the
Cardiac Pacemaker Devices Market
The key players in the global cardiac pacemaker devices market are
Medtronic PLC (Ireland), Abbott Laboratories (U.S.), Boston Scientific
Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), LivaNova PLC (U.K.),
Lepu Medical Technology Co ltd (China), Medico, S.p.A (Italy), Osypka Medical
GmbH (Germany), Shree Pacetronix Ltd (India), and Cook Medical Group (U.S.).
About Meticulous Research®
Meticulous
Research® is founded in 2010 and incorporated
as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company
under the Companies Act, 1956. Since its incorporation, the company has become
the leading provider of premium market intelligence in North America, Europe,
Asia-Pacific, Latin America, and Middle East & Africa.
Contact
Us:
Viren Shrivastava
Viren Shrivastava
AVP-
Global Sales and Marketing
Meticulous
Research®
Tel:
+1-646-781-8004
Email: viren@meticulousresearch.com
Comments
Post a Comment